BioXcel Therapeutics announces BXCL501 Programme initiative for prevention and treatment of acute agitation using wearable digital devices

Image: BioXcel will investigate the development of using wearable digital device technology such as the Apple Watch, with the goal of enhancing the prevention and treatment of agitation. Photo: courtesy of fancycrave1 from Pixabay.

Related Article
Recommended Whitepaper

View More